Tandem Diabetes Care (TNDM)

$116.83 4.32 (3.57%)

10:27 EDT TNDM Stock Quote Delayed 30 Minutes

Bret Kenwell

5 Top Stock Trades for Friday: SIG, MSFT, TNDM

By Bret Kenwell, InvestorPlace Contributor Jan 16, 2020

Signet Jewelers, Microsoft, Tandem Diabetes, InMode and Taiwan Semiconductor were our top stock trades for Friday -- and here's why.

8 Stocks to Buy That Are Growing Faster Than Amazon

10 Cheap Stocks to Buy Now

Why Tandem Diabetes Stock Will Rally Much Further

More Articles

Volume:

Previous Close -

Market Cap 7.36B

PE Ratio 614.89

EPS 0.19

Volume (Avg. Vol.) 111,020

Day's Range 116.01 - 120.00

52-Week Range 76.19 - 130.73

Dividend & Yield N/A (N/A)

TNDM Stock Predictions, Articles, and Tandem Diabetes Care News

From InvestorPlace
From the Web

5 Top Stock Trades for Tuesday: BAC, NFLX, ATVI, INTC

By Bret Kenwell, InvestorPlace Contributor Apr 1, 2019

Tandem Diabetes, Netflix, Activision Blizzard, Intel and Bank of America are our top stock trades to watch going into Tuesday.

Wait for the Inevitable Pullback to Buy TNDM Stock

By Will Healy, InvestorPlace Contributor Feb 28, 2019

TNDM stock should enjoy a bright, long-term future, but the quick run-up could mean Tandem Diabetes Care stock sees a near-term pullback.

5 Healthcare Stocks to Buy for Complete Portfolio Wellness

By Josh Enomoto, InvestorPlace Contributor Oct 10, 2018

Thanks to advancing technologies and a generally positive economy, healthcare stocks are back in the limelight.

Tandem Diabetes Is Firing on All Cylinders

By Chris Lau, InvestorPlace Contributor Sep 11, 2018

Tandem Diabetes sold shares of TNDM stock, but Tandem Diabetes stock continued to rocket higher. TNDM's Q2 results impressed investors, but its seasonally strong Q4 earnings could wow them more.

Why Tandem Stock Could Continue Its Rally

By Chris Lau, InvestorPlace Contributor Jun 25, 2018

Tandem stock rocketed to a new high after the company won an FDA approval and two analyst upgrades. At a one billion dollar market cap, the stock still has upside.

Tandem Diabetes Care Inc Is Up 194% — And It’s Not Done Yet

By Chris Lau, InvestorPlace Contributor Apr 13, 2018

Tandem Diabetes is firing on all cylinders and markets are already noticing. TNDM has more growth ahead than is currently priced into the stock.

4 Top Growth Picks as MedTech Battle Rages On

By Zacks Investment Research Oct 16, 2017

Trump’s Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization

From Benzinga Sep 9, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod

From Benzinga Sep 8, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

72 Biggest Movers From Yesterday

From Benzinga Sep 8, 2021

Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....

Why Tandem Diabetes Care Stock Jumped Today

From The Motley Fool Sep 7, 2021

The stock is being added to the S&P MidCap 400 Index.

45 Stocks Moving In Tuesday's Mid-Day Session

From Benzinga Sep 7, 2021

Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...

Analyzing Tandem Diabetes Care's Unusual Options Activity

From Benzinga Aug 5, 2021

On Thursday, shares of Tandem Diabetes Care (NASDAQ:TNDM)...